Akerna Corp KERN is moving higher on Wednesady morning after business intelligence from the company showed that April 20 had the highest retail cannabis sales ever recorded.
Approximately $111.8 million was recorded in medical and adult-use sales on the unofficial cannabis holiday "4/20."
Financial Results: Akerna last reported financial results on March 22.
"In the December quarter we delivered strong financial results, with 38 percent software growth year over year and 36 percent sequential improvement in adjusted EBITDA," said CEO Jessica Billingsley.
Price Action: Akerna has traded as high as $11.49 and as low as $2.17 over a 52-week period.
The stock was up 3.4% to $4.50 at last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.